BeNeLuxAI: Recent Experiences & Important Learnings

Who should attend this event?

Clients of AXIS Consulting, members, affiliates and stakeholders of IPHA as well as EFPIA members in Belgium, Luxembourg, Netherlands & Austria are invited to attend this free webinar.

Why should you attend this event?

The aim of the BeNeLuxAI initiative is to ensure sustainable access and affordable use of innovative medicines for patients. Over recent years the BeNeLuxAI collaborative has completed joint HTA assessments for a number of medicines. It is therefore timely to consider the key developments within the group and hear of the learnings of this joint collaborative comprising Belgium, Netherlands, Luxembourg, Austria and Ireland.
In addition to covering developments at BeNeLuxAI and the role of the pharmaceutical industry group in such collaborations, this webinar also provides an opportunity to hear about important updates on the International Horizon Scanning Initiative.

  • Thursday September 23, 2021
  • Virtual Event
  • 10:00am – 12.00pm BST

AXIS Autumn Masterclass: An Update on Pricing & Reimbursement in Ireland

The biannual AXIS Masterclasses are well received by industry professionals as a source of up to the minute information on the Irish Market Access landscape. The agenda for the Autumn Masterclass is currently being finalised and will focus on the forthcoming IPHA/HSE pricing agreement and managed access protocols.

The fee to attend is €250 ex VAT

  • Wednesday, October 20th, 2021
  • Virtual Event
  • 10:00am – 12.00pm BST

Current Events

ABPI - VPAS Virtual Town Hall Meeting

The current 2019 Voluntary scheme for branded medicines pricing and access (VPAS) has reached the mid-point and as such, the ABPI have conducted a strategic assessment with DHSC and NHSE to take stock of the key achievements to date and areas for improvement for the remaining period of the scheme.

Please note this is a date change from 12 July 2021.

The ABPI welcomes you to join them for the next Townhall Meeting, which will provide an update of the discussions following the Mid Scheme Review with relevant stakeholders and provide an insight to the early thinking of the next scheme.

This webinar is open to any company that is currently a member of the VPAS scheme. Visit the ABPI website to register.

  • Thursday 12 August 2021
  • Virtual
  • 10.00 am – 12.00 pm

EMIG Scotland Special Interest Group

Member-only event, to register for the event, click here.

  • Wednesday 23rd June 2021
  • Virtual
  • 10.00 am – 11.00 am

March 19th & 24th 2021 AXIS Virtual Market Access Masterclass - Access to New Medicines in Ireland- What’s Changing?

  • Fri, March 19, 2021 & Wed, March 24, 2021
  • Virtual Event
  • 9:00am – 12.30pm BST

Are you a Market Access Strategist based in Ireland or the UK with responsibility for developing a reimbursement submission to the Irish HTA assessment agency, the NCPE? Do you find it challenging to keep up to date with all the challenges in the Irish market access landscape? Would you like to be updated on and understand key changes occurring in 2021? 

Don’t miss our Spring 2021 Virtual Market Access Masterclass, normally a one-day event, this year’s masterclass will take place online over two half days. The virtual masterclass will provide you with an excellent opportunity to really get behind the scenes of the Irish system, learn how to avoid common submission pitfalls and hear of successful outcomes to reimbursement applications in Ireland.

  • Fri, March 19, 2021 & Wed, March 24, 2021
  • 9:00am – 12:30pm BST
  • Virtual event
  • Book Now

EMIG Scotland Special Interest Group

Speakers: Dr Andrew Walker, Director Salus Alba and ex reviewer at Scottish Medicines Consortium & Brenda Dooley, Chief Executive, AXIS Consulting & Managing Secretariat, EMIG Scotland

Andrew will update members on recent and key developments at the SMC. He will present his assessment of SMC decisions in 2020 as well as looking at the impact of the PACE process on the reimbursement of Orphan Medicines in Scotland including their use of modifiers. Andrew will also highlight the route taken by a number of medicines in Scotland on their journey to reimbursement

Brenda will then present highlights from the Scottish Landscape Report written and published by AXIS Consulting and comment on differences in the routes being pursued in Ireland for the same drugs as Andrew has highlighted for the SMC.

to include a Q & A session

  • Thursday 18th March 2021
  • Virtual Event
  • 11:00 am – 12:00 pm

THE PMI - Pharma Managers Series – HSE Briefing - Sponsored by AXIS Consulting

  • Thursday, November 5th , 2020
  • Virtual Event
  • 10:00 am – 11:00 am

At the PMI’s meeting on November 5th, Paul Reid, CEO at the HSE will give members an update on the Irish Health Service Executive

Paul Reid, Chief Executive Officer – HSE 

In May 2019 Paul Reid was appointed as Chief Executive Officer of the Health Service Executive where he now leads over 117,000 dedicated staff who deliver a wide range of health services across Ireland. Paul is a passionate public servant whose vision for the health service is to focus on long term planning by implementing Sláintecare and delivering effective and safe services within available resources. He is committed to building confidence and trust in our health service by supporting staff to deliver quality patient care through a new model of integrated services.

Prior to taking up the position of CEO at the HSE , Paul was Chief Executive of Fingal County Council, one of the largest Local Authorities in the state. Under his leadership over the period 2014-2019, Fingal was the leading local authority in terms of social and private housing development. It also led the way in terms of attracting Foreign Direct Investment and job creation across all sectors, through active land management and working with National State Agencies.

Between 2011 and 2014, Paul worked as the Chief Operations Officer in the Department of Public Expenditure & Reform. He was responsible for leading a whole set of reforms across the public service. In this role he negotiated the Haddington Road Agreement, with the 26 Public Service Trade Unions, to reduce the public service pay bill by €1BN.

Paul holds a Masters in Business Administration from Trinity College and a BA in Human Resources and Industrial Relations from the National College Ireland.

As Irelands leading provider of Market Access and Reimbursement submission services, AXIS Consulting is delighted to sponsor the PMI event on Nov 5th at which Paul Reid, CEO of the HSE will give an update on current and future activities within our health service. AXIS will also contribute to the agenda highlighting our recent research findings on reimbursement timelines in Ireland and also speak to some practical considerations to increase the speed at which new innovative medicines reach Irish patients


This event is proudly sponsored by:
axis health care consulting logo

Book Now

18th & 23rd Sept 2020 Market Access Virtual Masterclass
- Reimbursement in Ireland (Part 1 & 2)

  • September 18th & 23rd, 2020
  • Online Virtual Masterclass
  • Fri, 18 Sep 2020, 09:00am – 12.15pm & Wed, 23 Sep 2020, 09.00am – 12:15pm BST

Do you struggle to understand the Market Access landscape in Ireland? Are you spending valuable time trying to navigate the submission pathway? Would some strategic signposting and ‘on the ground’ local knowledge save you time and money?

Join AXIS CEO Brenda Dooley and her expert team for their Market Access Virtual Masterclass on Reimbursement Applications in Ireland. Normally a one day event, this year’s masterclass will take place online over two half days in September.

The virtual masterclass will provide you with an excellent opportunity to really get behind the scenes of the Irish system, learn how to avoid common submission pitfalls and hear of successful outcomes to reimbursement applications in Ireland.